Innovation Quarter tenant Carolina Liquid Chemistries Corp., located on the 4th floor of Wake Forest Biotech Place, engages in the business of developing, manufacturing and commercializing in vitro diagnostic reagents for quantitative testing of analytes, which are used in hospital and private laboratories worldwide. The company continues to grow and report upon its successes in the chemistry systems industry. It recently shared four announcements with the public regarding business successes:
Carolina Liquid Chemistries Corp. (CLC) announced on July 9 that its new Hemoglobin A1c (HbA1c) test, used on the CLC720™ chemistry analyzer received certification by the National lycohemoglobin Standardization Program (NGSP). Read the announcement.
Carolina Liquid Chemistries Corp. announced on May 28, 2014 that its “Vitamin D-directTM” test has received a “Moderate Complexity categorization by the Food and Drug Administration. Read the announcement.
Carolina Liquid Chemistries Corp. announced on May 28, 2014 that it has received 510(k) clearance from the Food and Drug Administration (FDA) to market its new CLC6410™ chemistry analyzer. Read the announcement.
Phil Shugart, founder of Carolina Liquid Chemistries Corp., received the award for “Entrepreneurial Excellence” at Triad BioNight 2014, the marquee event for the NC Piedmont Triad Region’s biotechnology community, held on May 21, 2014. Read the announcement.